Edition:
United Kingdom

Theravance Biopharma Inc (TBPH.OQ)

TBPH.OQ on NASDAQ Stock Exchange Global Market

24.59USD
14 Nov 2018
Change (% chg)

$-0.03 (-0.12%)
Prev Close
$24.62
Open
$24.84
Day's High
$25.19
Day's Low
$24.40
Volume
84,510
Avg. Vol
74,079
52-wk High
$35.48
52-wk Low
$21.27

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -1.07 December 15 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 4 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 1 1 2 2
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.57 2.57 2.75 2.75

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 6 20.93 43.50 10.40 7.17
Quarter Ending Mar-19 2 18.90 21.50 16.30 --
Year Ending Dec-18 6 65.87 88.13 55.00 47.85
Year Ending Dec-19 6 76.85 105.00 56.30 67.96
Earnings (per share)
Quarter Ending Dec-18 6 -1.07 -0.76 -1.41 -1.11
Quarter Ending Mar-19 2 -1.03 -1.02 -1.05 --
Year Ending Dec-18 6 -4.12 -3.76 -4.48 -4.27
Year Ending Dec-19 6 -4.27 -3.56 -4.77 -4.22

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 14.06 12.84 1.22 8.67
Quarter Ending Jun-18 10.67 23.48 12.81 120.08
Quarter Ending Mar-18 6.43 8.32 1.89 29.32
Quarter Ending Dec-17 4.84 4.51 0.33 6.77
Quarter Ending Sep-17 4.61 4.28 0.33 7.22

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 20.93 14.11 14.11 14.11 7.17
Quarter Ending Mar-19 18.90 15.46 15.46 15.46 --
Year Ending Dec-18 65.87 59.55 59.55 59.55 47.85
Year Ending Dec-19 76.85 81.04 80.76 80.76 67.96

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 3 1 3 1
Quarter Ending Mar-19 1 0 1 0
Year Ending Dec-18 4 0 4 0
Year Ending Dec-19 2 3 2 3
Earnings